Net Income

A new maternal blood test claims over 97% accuracy in predicting autism risk, offering hope for early intervention while igniting a fierce ethical debate.

New data reveals a surge in mental health leaves despite corporate investment, exposing a costly 'silent burnout' crisis hiding in plain sight.

U.S. Air Force awards Kraus Hamdani Aerospace a major contract for its K1000ULE drone, signaling a strategic shift in Middle East aerial warfare.

Matmut Group shatters records with a 56% profit surge, but its transformative acquisition of KOREGE signals a major strategic shift into savings and protection.

Enterprise Products Partners raises its distribution and buys back shares, showcasing financial strength ahead of key industry and earnings forecasts.

With its European trial launch, Kainova's DT-7012 aims to disarm cancer's bodyguards, offering new hope for patients with advanced solid tumors.

A new report reveals that where you live dictates your medical costs, with prices, not the care you use, driving a more than twofold spending gap.

Karl Blackburn, former head of Quebec’s top employers’ council, takes the helm at the Montreal Heart Institute Foundation, signaling a new era.

As Crocs sets its Q1 earnings call, all eyes are on the struggling HEYDUDE brand, contrasting with the core brand's strong international performance.

Eli Lilly's new once-daily oral GLP-1, Foundayo, is now on telehealth platform Ro, offering a convenient, needle-free alternative to injectable drugs.

Ease.io's annual awards highlight the leaders and technologies redefining factory excellence, from individual trailblazers to data-driven plant transformations.

Following a $47.5M funding round, CertifID is bolstering its leadership to fight a new wave of sophisticated, AI-driven wire fraud in real estate.

China's EdTech giant TAL is set to report Q4 earnings. Investors are watching closely to see if its pivot to AI and smart devices is a winning strategy.

Appliance giant Electrolux is set to release its Q1 results. Investors are watching to see if cost-cutting can overcome weak consumer demand.

Whitestone REIT holds its dividend steady, backed by record occupancy, strong financials, and a unique strategy in high-growth Sun Belt markets.

The ONEflight Myrtle Beach Classic blends PGA TOUR golf with F1 speed, Hollywood stars, and a Beach Boys concert, redefining the luxury sports experience.

A new nonprofit is using crypto transaction fees to fight childhood hunger, partnering with Feed the Children in a bold new experiment for philanthropy.

Following a massive stock surge, Forte Biosciences is raising $150M. The funds are crucial for a pivotal year of clinical trials for its autoimmune drug.

The retailer posts modest annual growth despite a tough Q4, as international gains and efficiency drives offset major headwinds in its Canadian operations.

With its lead drug in Phase 3 and a strong Biogen partnership, Stoke Therapeutics prepares to update investors on its disease-modifying Dravet syndrome therapy.